HP and sickle cell disease: We identified delayed anemia after ARS treatment using a small subgroup of patients from the current study [16] in whom it was possible to study anemia defined by several criteria (low haptoglobin, elevated lactate dehydrogenase level, decrease inHb, exclusion of sickle cell disease and G6PDH deficiency).